Ketamine and the Default Mode Network: Neuroimaging Evidence

Ketamine and the default mode network are linked through a well-replicated two-phase pattern in the neuroimaging literature: a sub-anesthetic dose acutely disrupts connectivity within the default mode network (DMN), the brain network tied to self-referential rumination in depression, and that disruption gives way to a period of DMN reconfiguration that tracks with antidepressant response. The DMN is a set of interconnected brain regions, including the medial prefrontal cortex (mPFC), posterior cingulate cortex (PCC), precuneus, angular gyrus, and medial temporal lobe structures, that activate during rest and self-referential thought and deactivate during externally focused tasks. This article reviews the ketamine and the default mode network neuroimaging evidence from fMRI, MEG, and PET studies, and what it means for predicting and monitoring treatment response.

The Default Mode Network in Health and Depression

The DMN was first characterized by Raichle and colleagues (2001) in the Proceedings of the National Academy of Sciences as a set of brain regions that deactivate during externally directed tasks and activate during rest, self-referential thought, autobiographical memory retrieval, and future simulation. Because the network centers on self-focused cognition, it sits at the middle of neurobiological models of depression, which frame depressive rumination, the persistent, maladaptive focus on negative self-referent thoughts, as a consequence of DMN hyperconnectivity and dysregulated self-referential processing (Hamilton et al., 2015). According to the World Health Organization, depression affects an estimated 280 million people worldwide, making it one of the leading causes of disability globally (WHO Depression Fact Sheet).

Evidence for DMN Hyperconnectivity

A large body of resting-state functional MRI (rs-fMRI) research documents altered DMN connectivity in major depressive disorder. The most consistent finding is hyperconnectivity within the DMN, particularly between the mPFC and PCC, in depressed individuals compared with healthy controls (Greicius et al., 2007). Kaiser and colleagues (2015), in a meta-analysis published in JAMA Psychiatry, analyzed resting-state connectivity data across 25 studies encompassing more than 550 depressed patients and 500 healthy controls. The analysis confirmed significant hyperconnectivity within the anterior, mPFC-centered DMN in depression, along with reduced connectivity between the DMN and the frontoparietal control network, suggesting impaired regulatory oversight of self-referential processes.

Subgenual Anterior Cingulate Cortex

The subgenual anterior cingulate cortex (sgACC, Brodmann area 25) is a DMN-associated region identified as a critical node in the neurocircuitry of depression. It shows increased metabolic activity and functional connectivity with other DMN regions in depression, and normalization of sgACC hyperactivity is associated with antidepressant response across pharmacotherapy, electroconvulsive therapy (ECT), and deep brain stimulation (Mayberg et al., 2005). Because the sgACC responds to such different treatment mechanisms, it is a candidate neuroimaging biomarker for predicting treatment response.

Acute Effects of Ketamine on DMN Connectivity

fMRI Studies During Ketamine Infusion

Scheidegger and colleagues (2012), published in Human Brain Mapping, ran one of the first studies examining ketamine's acute effects on resting-state networks. In 17 healthy volunteers, sub-anesthetic ketamine (a 0.25 mg/kg IV bolus followed by continuous infusion) produced a significant reduction in within-network DMN connectivity, with the largest decrease in PCC-mPFC coupling. This acute DMN disruption correlated with the subjective experience of ego dissolution and derealization, core features of the dissociative state ketamine produces at these doses.

Bonhomme and colleagues (2016) replicated and extended these findings using both rs-fMRI and EEG, showing that ketamine-induced DMN disconnection occurs in a dose-dependent manner and tracks changes in conscious experience. At the highest sub-anesthetic doses studied, DMN connectivity approached levels seen during propofol-induced unconsciousness, suggesting a continuum of DMN disruption across the sedation-anesthesia spectrum.

Magnetoencephalography Evidence

Magnetoencephalography (MEG) is a neuroimaging technique that measures the magnetic fields produced by neural electrical activity, offering higher temporal resolution than fMRI. Muthukumaraswamy and colleagues (2015), published in NeuroImage, used MEG to show that ketamine produces broadband reductions in oscillatory power across cortical regions, with a particular effect on alpha-band (8-13 Hz) and theta-band (4-8 Hz) power within DMN regions. Because reduced alpha power is thought to interrupt the cortical idling state associated with self-referential processing, these oscillatory changes may be the electrophysiological mechanism behind ketamine's disruption of DMN function.

Post-Ketamine DMN Changes and Therapeutic Relevance

24-Hour Post-Infusion Connectivity

Ketamine's effects on DMN connectivity extend well beyond the acute drug state. Several studies show DMN connectivity changes persist, or emerge in new configurations, at 24 to 48 hours post-infusion, the same window associated with peak antidepressant effect. Abdallah and colleagues (2017), published in Biological Psychiatry, examined resting-state connectivity in treatment-resistant depression patients before and 24 hours after a ketamine infusion. Responders showed significant normalization of DMN hyperconnectivity, specifically a reduction in the excessive sgACC-to-DMN coupling present at baseline. Non-responders showed no such normalization.

Evans and colleagues (2018), published in Molecular Psychiatry, reported that ketamine-induced increases in global brain connectivity (GBC), a measure of how connected each brain region is to all others, were most pronounced in the prefrontal cortex and correlated with antidepressant response at 24 hours. These prefrontal GBC increases occurred specifically in regions associated with executive control networks, suggesting ketamine rebalances the relationship between the DMN and executive control networks in a direction that supports symptom improvement.

Longitudinal Connectivity Changes with Repeated Infusions

Li and colleagues (2020), published in Translational Psychiatry, tracked DMN connectivity across a series of six ketamine infusions in patients with treatment-resistant depression. Progressive normalization of DMN hyperconnectivity accompanied successive infusions, and the degree of normalization by the end of the series predicted sustained antidepressant response at follow-up. This finding lines up with the clinical pattern described in our guide on how many ketamine treatments are typically needed, and suggests repeated dosing produces cumulative network-level plasticity rather than a single reset.

DMN Subnetworks and Ketamine Response

Anterior Versus Posterior DMN

The DMN splits into anterior (mPFC-centered) and posterior (PCC/precuneus-centered) subnetworks with partly separate functions. The anterior DMN is more tied to self-referential evaluation and emotional processing, while the posterior DMN supports autobiographical memory and contextual processing (Andrews-Hanna et al., 2010). Evidence suggests ketamine affects these subnetworks differently: acute disruption is more pronounced in posterior DMN connectivity, while the therapeutically relevant normalization at the 24-hour mark is more pronounced in the anterior DMN (Lehmann et al., 2016).

DMN-Salience Network Interaction

The salience network, anchored in the anterior insula and dorsal anterior cingulate cortex, acts as a switch that mediates transitions between DMN-dominated internal processing and task-positive network-dominated external engagement (Menon, 2011). In depression, impaired salience network function may contribute to an inability to disengage from ruminative self-focus. Ketamine has been shown to strengthen salience network connectivity and the anti-correlation between the DMN and task-positive networks, a pattern associated with improved cognitive flexibility and reduced rumination (Kraus et al., 2020).

Predictive Biomarkers: DMN Connectivity as a Treatment Response Predictor

Baseline Connectivity Predictors

Using pre-treatment DMN connectivity patterns to predict ketamine response is a high-priority research goal, and it connects to the broader work covered in our guide to biomarkers of ketamine response. Preliminary evidence suggests baseline DMN hyperconnectivity, somewhat counterintuitively, predicts a better response to ketamine. Abdallah and colleagues (2017) reported that patients with greater pre-treatment sgACC-DMN connectivity showed larger antidepressant responses, possibly because they had more room for normalization in this network measure.

Mkrtchian and colleagues (2021), published in Neuropsychopharmacology, applied machine learning to pre-treatment resting-state fMRI data and predicted ketamine response with approximately 80% accuracy, using features drawn from DMN connectivity, executive control network function, and inter-network coupling. These models still need prospective validation, but they demonstrate that neuroimaging-guided patient selection for ketamine therapy is technically feasible.

Real-Time Connectivity Monitoring

Advances in real-time fMRI neurofeedback raise the possibility of monitoring DMN connectivity during a ketamine infusion and adjusting dose or infusion parameters based on the network changes observed in real time. This closed-loop approach is technologically demanding and remains at the proof-of-concept stage.

Mechanistic Implications

NMDA Receptor Blockade and Network Disruption

Ketamine's primary molecular target is the N-methyl-D-aspartate (NMDA) receptor, a glutamate receptor involved in synaptic signaling and plasticity. PubChem's ketamine compound summary documents this receptor-binding profile. Researchers hypothesize that the acute DMN disruption ketamine produces results from NMDA receptor blockade on cortical GABAergic interneurons, particularly within DMN hub regions. This interneuron disinhibition produces a glutamate surge that transiently disrupts the coordinated low-frequency oscillations, especially in the alpha and theta bands, that maintain DMN connectivity (Anticevic et al., 2012). The disruption works like a reset of network dynamics, opening a window of decoupled processing during which maladaptive connectivity patterns may be overwritten.

Synaptic Plasticity and Connectivity Restoration

The post-acute normalization of DMN connectivity at 24 to 48 hours is thought to reflect structural plasticity triggered by ketamine's downstream molecular signaling, including BDNF release, mTORC1 activation, and dendritic spine formation in prefrontal cortex neurons. Our guide to ketamine's neuroplasticity mechanisms covers this signaling cascade in more detail. This synaptogenesis may selectively strengthen adaptive connectivity patterns between the DMN and regulatory networks, while allowing maladaptive DMN hyperconnectivity to weaken, producing the net connectivity normalization seen in neuroimaging studies (Duman et al., 2016).

Comparison with Other Antidepressant Modalities

Ketamine's effect on DMN connectivity looks different from other antidepressant interventions in both speed and magnitude. SSRI treatment over weeks to months produces gradual normalization of DMN hyperconnectivity, as shown in longitudinal fMRI studies (Posner et al., 2013). ECT produces faster DMN connectivity changes, with reduced hyperconnectivity detectable after three to six sessions (Mulders et al., 2015). Ketamine's distinguishing feature is the speed and size of its DMN modulation: it produces network-level changes within hours, a timeline that mirrors its clinical antidepressant effect. This overlap in timing supports the hypothesis that DMN connectivity changes are mechanistically linked to, rather than merely correlated with, antidepressant response.

Future Directions and Conclusion

Research priorities in this area include prospective validation of DMN-based response prediction models, mechanistic studies linking specific DMN connectivity changes to specific symptom dimensions such as rumination, anhedonia, and suicidal ideation, and work to determine whether DMN connectivity changes mediate or simply accompany clinical outcomes. Combining multimodal neuroimaging (fMRI, PET, MEG) with peripheral biomarkers and genetic data in large, multi-site studies will be needed to move DMN research from correlation to a tool clinicians can use.

The neuroimaging evidence gathered so far shows that sub-anesthetic ketamine produces fast, therapeutically relevant changes to the default mode network. Acute administration disrupts DMN connectivity in a pattern consistent with reduced self-referential processing, and post-acute normalization at 24 to 48 hours correlates with antidepressant response. These network-level effects give researchers a systems-neuroscience framework for understanding ketamine's mechanism of action, and they point toward neuroimaging biomarkers that could eventually guide patient selection, treatment optimization, and response monitoring. The DMN looks less like a side effect of ketamine's action and more like part of the mechanism through which NMDA receptor modulation produces a rapid antidepressant effect. For background on how this topic fits into the broader depression research agenda, see the NIMH depression overview.